CSHL1 | Chorionic somatomammotropin hormone-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
PSG1 | Pregnancy specific beta-1-glycoprotein 1 | CD markers Predicted secreted proteins
| | | | | Tissue enriched |
PSG11 | Pregnancy specific beta-1-glycoprotein 11 | Predicted secreted proteins
| | | | | Tissue enriched |
PSG2 | Pregnancy specific beta-1-glycoprotein 2 | Predicted secreted proteins
| | | | | Tissue enriched |
PSG9 | Pregnancy specific beta-1-glycoprotein 9 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CSH2 | Chorionic somatomammotropin hormone 2 | Predicted secreted proteins
| | | | | Tissue enriched |
PSG8 | Pregnancy specific beta-1-glycoprotein 8 | Predicted secreted proteins
| | | | | Tissue enriched |
PSG5 | Pregnancy specific beta-1-glycoprotein 5 | Predicted secreted proteins
| | | | | Tissue enriched |
PSG6 | Pregnancy specific beta-1-glycoprotein 6 | Predicted secreted proteins
| | | | | Tissue enriched |
LGALS14 | Lectin, galactoside-binding, soluble, 14 | | | | | | Tissue enriched |
KISS1 | KiSS-1 metastasis-suppressor | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
PSG3 | Pregnancy specific beta-1-glycoprotein 3 | Predicted secreted proteins
| | | | | Tissue enriched |
CSH1 | Chorionic somatomammotropin hormone 1 (placental lactogen) | Predicted secreted proteins
| | | | | Tissue enriched |
INSL4 | Insulin-like 4 (placenta) | Predicted secreted proteins
| | | | | Tissue enriched |
GH2 | Growth hormone 2 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB5 | Chorionic gonadotropin, beta polypeptide 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AC008394.1 | Uncharacterized protein | | | | | | Tissue enriched |
ERVV-2 | Endogenous retrovirus group V, member 2 | Predicted membrane proteins
| | | | | Tissue enriched |
LGALS13 | Lectin, galactoside-binding, soluble, 13 | | | | | | Tissue enriched |
CGB | Chorionic gonadotropin, beta polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PSG4 | Pregnancy specific beta-1-glycoprotein 4 | Predicted secreted proteins
| | | | | Tissue enriched |
ISM2 | Isthmin 2 | Predicted secreted proteins
| | | | | Tissue enriched |
KRTAP26-1 | Keratin associated protein 26-1 | | | | | | Tissue enriched |
CGB1 | Chorionic gonadotropin, beta polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enriched |
XAGE3 | X antigen family, member 3 | | | | | | Tissue enriched |
ERVV-1 | Endogenous retrovirus group V, member 1 | Predicted membrane proteins
| | | | | Tissue enriched |
XAGE2 | X antigen family, member 2 | | | | | | Tissue enriched |
XAGE2B | X antigen family, member 2B | | | | | | Tissue enriched |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
FAM26D | Family with sequence similarity 26, member D | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PLAC1 | Placenta-specific 1 | Predicted secreted proteins
| | | | | Tissue enriched |
ERVFRD-1 | Endogenous retrovirus group FRD, member 1 | Predicted membrane proteins
| | | | | Tissue enriched |
PAPPA-AS1 | PAPPA antisense RNA 1 | Predicted membrane proteins
| | | | | Tissue enriched |
PAPPA2 | Pappalysin 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
CRH | Corticotropin releasing hormone | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LGALS16 | Lectin, galactoside-binding, soluble, 16 | | | | | | Tissue enriched |
ALPP | Alkaline phosphatase, placental | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enriched |
TFPI2 | Tissue factor pathway inhibitor 2 | Predicted secreted proteins
| | | | | Tissue enriched |
LINC01118 | Long intergenic non-protein coding RNA 1118 | | | | | | Tissue enriched |
HBG1 | Hemoglobin, gamma A | | | | | | Tissue enriched |
SIGLEC6 | Sialic acid binding Ig-like lectin 6 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
HBG2 | Hemoglobin, gamma G | Disease related genes Plasma proteins
| | | | | Tissue enriched |
GCM1 | Glial cells missing homolog 1 (Drosophila) | Transcription factors
| | | | | Tissue enriched |
HSD17B1 | Hydroxysteroid (17-beta) dehydrogenase 1 | Enzymes
| | | | | Tissue enriched |
NOTUM | Notum pectinacetylesterase homolog (Drosophila) | Predicted secreted proteins
| | | | | Tissue enriched |
CGA | Glycoprotein hormones, alpha polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |